{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-007964","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.029394+00:00","generated_at":"2026-06-05T07:38:29.625240+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioLife Q4 rev $32.7M (-26% YoY); guides 2024 rev $95.5-100M ex-freezer; adj EBITDA positive","bullets":["Q4 GAAP net loss $13.4M ($0.30 loss/share) vs $49.2M loss ($1.15) in Q4 2022.","Cell Processing platform Q4 rev $14.8M, down 27% YoY but up 11% sequentially.","Freezer divestiture underway; expects sale by end of Q1 2024.","2024 revenue guidance $95.5-100.0M (ex-freezer); expects full-year positive adjusted EBITDA.","Biopreservation media embedded in 14 approved CGT therapies as of Feb 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-007964","json":"https://secwatch.observer/filing/0001628280-24-007964.json","markdown":"https://secwatch.observer/filing/0001628280-24-007964.md","text":"https://secwatch.observer/filing/0001628280-24-007964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/0001628280-24-007964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/blfs-20240229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:38:29.625240+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b5dda5d8458f2647313dac7897b8f7bdfcbd53f","claim":"BIOLIFE SOLUTIONS INC updated its the fourth quarter and year ended December 31, 2023 guidance (initiated).","evidence_excerpt":"On February 29, 2024, BioLife Solutions, Inc., a Delaware corporation, issued a press release announcing financial results and operational highlights for the fourth quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024007964/0001628280-24-007964-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}